Systems immunology: Just getting started

Nature Immunology

Volumn 18, Issue 7, 2017, Pages 725-732

  Davis, Mark M ^a   Tato, Cristina M ^a   Furman, David ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; CD4 ANTIGEN; CELL SURFACE MARKER; CELL SURFACE RECEPTOR; CHEMOKINE; CYTOKINE; VACCINE;

ADAPTIVE IMMUNITY; AGING; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; GENETICS; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGY; INFECTION; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALIGNANT NEOPLASM; NATURAL KILLER CELL; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW; SYSTEMS BIOLOGY; T LYMPHOCYTE; VACCINATION; IMMUNE SYSTEM; IMMUNOLOGICAL TECHNIQUE; PROCEDURES; SIGNAL TRANSDUCTION;

ALLERGY AND IMMUNOLOGY; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC TECHNIQUES; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; VACCINES;

EID: 85020995463     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3768     Document Type: Review

References (83)

1. Morrissette, N.S. et al. Isolation and characterization of monoclonal antibodies directed against novel components of macrophage phagosomes. J. Cell Sci. 112, 4705-4713 (1999).
2. Aderem, A. Phagocytosis and the inflammatory response. J. Infect. Dis. 187, S340-S345 (2003).
3. Lienert, F., Lohmueller, J.J., Garg, A. & Silver, P.A. Synthetic biology in mammalian cells: next generation research tools and therapeutics. Nat. Rev. Mol. Cell Biol. 15, 95-107 (2014).
4. Irvine, D.J., Purbhoo, M.A., Krogsgaard, M. & Davis, M.M. Direct observation of ligand recognition by T cells. Nature 419, 845-849 (2002).
5. Huang, J. et al. A single peptide-major histocompatibility complex ligand triggers digital cytokine secretion in CD4(+) T cells. Immunity 39, 846-857 (2013).
6. Hood, L., Heath, J.R., Phelps, M.E. & Lin, B. Systems biology and new technologies enable predictive and preventative medicine. Science 306, 640-643 (2004).
7. Furman, D. & Davis, M.M. New approaches to understanding the immune response to vaccination and infection. Vaccine 33, 5271-5281 (2015).
8. Kidd, B.A., Peters, L.A., Schadt, E.E. & Dudley, J.T. Unifying immunology with informatics and multiscale biology. Nat. Immunol. 15, 118-127 (2014).
9. Yu, W. et al. Clonal deletion prunes but does not eliminate self-specific CD8+ T lymphocytes. Immunity 42, 929-941 (2015).
10. Segal, E. et al. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat. Genet. 34, 166-176 (2003).
11. Chaussabel, D. et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29, 150-164 (2008).
12. Shen-Orr, S.S. et al. Cell type-specific gene expression differences in complex tissues. Nat. Methods 7, 287-289 (2010).
13. Zhao, Y. & Simon, R. Gene expression deconvolution in clinical samples. Genome Med. 2, 93 (2010).
14. Zhong, Y. & Liu, Z. Gene expression deconvolution in linear space. Nat. Methods 9, 8-9 (2011).
15. Shen-Orr, S.S. & Gaujoux, R. Computational deconvolution: extracting cell type-specific information from heterogeneous samples. Curr. Opin. Immunol. 25, 571-578 (2013).
16. Wang, L., Oh, W.K. & Zhu, J. Disease-specific classification using deconvoluted whole blood gene expression. Sci. Rep. 6, 32976 (2016).
17. Newman, A.M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453-457 (2015).
18. Tikhonov, A.N. Solution of incorrectly formulated problems and the regularization method. Soviet Mathematics Doklady 4, 1035-1038 (1963).
19. Tibshirani, R. Regression shrinkage and selection via the lasso. J. R. Stat. Soc. B 58, 267-288 (1996).
20. Zou HaH, T. Regularization and variable selection via the elastic net. J. R. Stat. Soc. B 67, 301-320 (2005).
21. Zak, D.E. et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet 387, 2312-2322 (2016).
22. Sweeney, T.E., Braviak, L., Tato, C.M. & Khatri, P. Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Respir. Med. 4, 213-224 (2016).
23. Andres-Terre, M. et al. Integrated, multi-cohort analysis identifies conserved transcriptional signatures across multiple respiratory viruses. Immunity 43, 1199-1211 (2015).
24. Bendall, S.C. et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332, 687-696 (2011).
25. Qiu, P. et al. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat. Biotechnol. 29, 886-891 (2011).
26. Bendall, S.C. & Nolan, G.P. From single cells to deep phenotypes in cancer. Nat. Biotechnol. 30, 639-647 (2012).
27. Horowitz, A. et al. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci. Transl. Med. 5, 208ra145 (2013).
28. Newell, E.W., Sigal, N., Bendall, S.C., Nolan, G.P. & Davis, M.M. Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity 36, 142-152 (2012).
29. Simoni, Y. et al. Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency. Immunity 46, 148-161 (2017).
30. Kay, A.W., Strauss-Albee, D.M. & Blish, C.A. Application of mass cytometry (CyTOF) for functional and phenotypic analysis of natural killer cells. Methods Mol. Biol. 1441, 13-26 (2016).
31. Yao, Y. et al. CyTOF supports efficient detection of immune cell subsets from small samples. J. Immunol. Methods 415, 1-5 (2014).
32. Dixit, A. et al. Perturb-Seq: dissecting molecular circuits with scalable single-cell RNA profiling of pooled genetic screens. Cell 167, 1853-1866 (2016).
33. Datlinger, P. et al. Pooled CRISPR screening with single-cell transcriptome readout. Nat. Methods 14, 297-301 (2017).
34. Jaitin, D.A. et al. Dissecting immune circuits by linking CRISPR-pooled screens with single-cell RNA-Seq. Cell 167, 1883-1896 (2016).
35. Pulendran, B. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat. Rev. Immunol. 9, 741-747 (2009).
36. Gaucher, D. et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205, 3119-3131 (2008).
37. Querec, T.D. et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10, 116-125 (2009).
38. Haralambieva, I.H. et al. Transcriptional signatures of influenza A/H1N1-specific IgG memory-like B cell response in older individuals. Vaccine 34, 3993-4002 (2016).
39. Haralambieva, I.H. et al. Whole transcriptome profiling identifies CD93 and other plasma cell survival factor genes associated with measles-specific antibody response after vaccination. PLoS One 11, e0160970 (2016).
40. Ovsyannikova, I.G. et al. Gene signatures associated with adaptive humoral immunity following seasonal influenza A/H1N1 vaccination. Genes Immun. 17, 371-379 (2016).
41. Nakaya, H.I. et al. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 12, 786-795 (2011).
42. Furman, D. et al. Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol. Syst. Biol. 9, 659 (2013).
43. Price, J.V. et al. Characterization of influenza vaccine immunogenicity using influenza antigen microarrays. PLoS One 8, e64555 (2013).
44. Furman, D. et al. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc. Natl. Acad. Sci. USA 111, 869-874 (2014).
45. Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 15, 195-204 (2014).
46. Goodwin, K., Viboud, C. & Simonsen, L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24, 1159-1169 (2006).
47. Kazmin, D. et al. Systems analysis of protective immune responses to RTS,S malaria vaccination in humans. Proc. Natl. Acad. Sci. USA 114, 2425-2430 (2017).
48. Furman, D. Sexual dimorphism in immunity: improving our understanding of vaccine immune responses in men. Expert Rev. Vaccines 14, 461-471 (2015).
49. Ravindran, R. et al. Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation. Science 343, 313-317 (2014).
50. Oh, J.Z. et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 41, 478-492 (2014).
51. Lëvy, Y. et al. Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load. Eur. J. Immunol. 44, 2802-2810 (2014).
52. Obermoser, G. et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 38, 831-844 (2013).
53. Weng, N.P., Akbar, A.N. & Goronzy, J. CD28 T cells: their role in the age-associated decline of immune function. Trends Immunol. 30, 306-312 (2009).
54. Qi, Q. et al. Diversity and clonal selection in the human T-cell repertoire. Proc. Natl. Acad. Sci. USA 111, 13139-13144 (2014).
55. Goronzy, J.J., Fang, F., Cavanagh, M.M., Qi, Q. & Weyand, C.M. Naive T cell maintenance and function in human aging. J. Immunol. 194, 4073-4080 (2015).
56. Shen-Orr, S.S. et al. Defective signaling in the JAK-STAT pathway tracks with chronic inflammation and cardiovascular risk in aging humans. Cell Systems 3, 374-384 (2016).
57. Furman, D. et al. Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states. Nat. Med. 23, 174-184 (2017).
58. Romero, P. et al. The Human Vaccines Project: A roadmap for cancer vaccine development. Sci. Transl. Med. 8, 334ps9 (2016).
59. Gubin, M.M. et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515, 577-581 (2014).
60. van Rooij, N. et al. Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma. J. Clin. Oncol. 31, e439-e442 (2013).
61. Snyder, A. et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N. Engl. J. Med. 371, 2189-2199 (2014).
62. Spitzer, M.H. et al. Systemic immunity is required for effective cancer immunotherapy. Cell 168, 487-502 (2017).
63. Han, A. et al. Dietary gluten triggers concomitant activation of CD4+ and CD8+ T cells and T cells in celiac disease. Proc. Natl. Acad. Sci. USA 110, 13073-13078 (2013).
64. Blazkova, J. et al. Multicenter Systems analysis of human blood reveals immature neutrophils in males and during pregnancy. J. Immunol. 198, 2479-2488 (2017).
65. Banchereau, R. et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell 165, 551-565 (2016).
66. Brodin, P. et al. Variation in the human immune system is largely driven by non-heritable influences. Cell 160, 37-47 (2015).
67. Casanova, J.L. Severe infectious diseases of childhood as monogenic inborn errors of immunity. Proc. Natl. Acad. Sci. USA 112, E7128-E7137 (2015).
68. Casanova, J.L. Human genetic basis of interindividual variability in the course of infection. Proc. Natl. Acad. Sci. USA 112, E7118-E7127 (2015).
69. Conley, M.E. & Casanova, J.L. Discovery of single-gene inborn errors of immunity by next generation sequencing. Curr. Opin. Immunol. 30, 17-23 (2014).
70. Boyd, S.D. et al. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci. Transl. Med. 1, 12ra23 (2009).
71. Weinstein, J.A., Jiang, N., White, R.A. III, Fisher, D.S. & Quake, S.R. High-throughput sequencing of the zebrafish antibody repertoire. Science 324, 807-810 (2009).
72. Robinson, W.H. Sequencing the functional antibody repertoire-diagnostic and therapeutic discovery. Nat. Rev. Rheumatol. 11, 171-182 (2015).
73. Jackson, K.J. et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell Host Microbe 16, 105-114 (2014).
74. Newell, E.W. et al. Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. Nat. Biotechnol. 31, 623-629 (2013).
75. Warren, R.L. et al. Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes. Genome Res 21, 790-797 (2011).
76. Becattini, S. et al. T cell immunity. Functional heterogeneity of human memory CD4+ T cell clones primed by pathogens or vaccines. Science 347, 400-406 (2015).
77. Han, A., Glanville, J., Hansmann, L. & Davis, M.M. Linking T-cell receptor sequence to functional phenotype at the single-cell level. Nat. Biotechnol. 32, 684-692 (2014).
78. Stubbington, M.J. et al. T cell fate and clonality inference from single-cell transcriptomes. Nat. Methods 13, 329-332 (2016).
79. Heather, J.M., Ismail, M., Oakes, T. & Chain, B. High-throughput sequencing of the T-cell receptor repertoire: pitfalls and opportunities. Brief. Bioinform. https://dx.doi.org/10.1093/bib/bbw138 (2017).
80. Cinelli, M. et al. Feature selection using a one dimensional naïve Bayes' classifier increases the accuracy of support vector machine classification of CDR3 repertoires. Bioinformatics 33, 951-955 (2017).
81. Davis, M.M. A prescription for human immunology. Immunity 29, 835-838 (2008).
82. Gaudillière, B. et al. Clinical recovery from surgery correlates with single-cell immune signatures. Sci. Transl. Med. 6, 255ra131 (2014).
83. Fragiadakis, G.K. et al. Patient-specific immune states before surgery are strong correlates of surgical recovery. Anesthesiology 123, 1241-1255 (2015).